RIFAMPICIN-RESISTANT TUBERCULOSIS
Clinical trials for RIFAMPICIN-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new RIFAMPICIN-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for RIFAMPICIN-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course drug regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo alongside standard antibiotics. The go…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 25, 2026 17:06 UTC
-
New 9-Month pill regimen could transform Drug-Resistant TB care
Disease control Not yet recruitingThis study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis. About 120 participants aged 12 and older will take the pills and be monitored for 24 months. The goal is to see if this shorter treatment works well and is safe for Chi…
Matched conditions: RIFAMPICIN-RESISTANT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 25, 2026 16:57 UTC